North America In-Vitro Diagnostics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product and Services (Reagents and Kits, Instruments, and Software and Services); Technology (Immunoassay/ Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Microbiology, Blood Glucose Self-Monitoring, Coagulation & Hemostasis, Hematology, Urinalysis, and Others); Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Autoimmune Diseases, Nephrology, and Others); End User (Hospitals, Laboratories, Homecare, and Others)

Abstract
The in-vitro diagnostics market in North America is expected to grow from US$ 26,981.2 million in 2019 to US$ 38,759.6 million by 2027; it is estimated to grow at a CAGR of 4.7% from 2020 to 2027. Aging population is vastly vulnerable to viral infections as well as chronic conditions. For instance, according to the research conducted by American Diabetes Association in 2017, an estimated one-third population of adults in the US over age 65 was suffering from diabetes. Diabetes in adults generates higher risk of functional limitations, loss of independence, frailty, and disability. Also, according to a study conducted by the American Heart Association in 2017, by 2030, 40.0% of all deaths among elderly population would be caused due to cardiovascular diseases across the globe. Factors such as limiting the overall physiological processes, smoking and tobacco consumption, increased arterial stiffness, and hypertension may develop the risk of developing cardiovascular diseases among adult population. Therefore, increasing prevalence of diabetes and cardiovascular diseases among adults offers lucrative environment for the growth of the in-vitro diagnostics market in North America. Furthermore, according to a report of the United Nations (2017), the number of the elderly population is expected to grow significantly in Africa, followed by North America, Latin America & the Caribbean, and Asia Pacific. The elderly people are more prone to chronic conditions. Increasing adult population is generating demand for advanced diagnostic systems, which is projected to drive the market growth during the forecast period.

The North America in-vitro diagnostics market is segmented on the basis of product and services, technology, application, and end user. Based on product and services, the market is segmented into reagents and kits, instruments, and software and services. In 2019, the instruments and kits segment accounted for the largest market share. The market for the instruments and kits segment is expected to grow during the forecast period owing to the increasing adoption of in-vitro diagnostics across the region. Moreover, factors such as the increasing prevalence of chronic diseases coupled with growing awareness and availability of the product in considerable margins are projected to drive the market growth for the instruments and kits segment during the forecast period.

The US is the most affected country across the region as it reported significant mortalities due to SARS-CoV-2 virus infection. For the diagnosis of COVID-19 among the people, the demand for in vitro diagnostics and rapid tests increased rapidly. In addition, various companies have shifted their focus to molecular diagnostics and testing. Thus, there is an exponential rise in the demand for RT-PCR procedures, assays, kits, and reagents, as these diagnostic technologies offer results in less time. Also, the companies operating in this particular segment (IVD) have generated profits. This way, the COVID-19 outbreak offered significant growth opportunities for the in-vitro diagnostics market in North America.

The overall North America in-vitro diagnostics market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the North America in-vitro diagnostics market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers, along with external consultants such as valuation experts, research analysts, and key opinion leaders, specializing in the North America in-vitro diagnostics market. F. HOFFMANN-LA ROCHE LTD.; DANAHER; ABBOTT; SIEMENS AG; SYSMEX CORPORATION; THERMO FISHER SCIENTIFIC, INC.; BD; BIOMERIEUX SA; BIO-RAD LABORATORIES, INC.; and QIAGEN are among the players operating in the market.

Content
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 In-Vitro Diagnostics Market – By Product and Services
1.3.2 In-Vitro Diagnostics Market – By Technology
1.3.3 In-Vitro Diagnostics Market – By Application
1.3.4 In-Vitro Diagnostics Market – By End User
1.3.5 North America In-Vitro Diagnostics Market – By Country
2. North America In-Vitro Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America In-Vitro Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 In-Vitro Diagnostics Market- North America PEST Analysis
4.3 Expert Opinion
5. North America In-Vitro Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Growing Geriatric Population
5.1.3 Rising Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraints
5.2.1 Lack of Healthcare Infrastructure and Reimbursement Policies
5.3 Future Trends
5.3.1 Increasing Adoption and Popularity of Automation in Clinical Laboratories
5.4 Impact Analysis
6. In-Vitro Diagnostics Market – North America Analysis
6.1 North America In-Vitro Diagnostics Market Revenue Forecasts and Analysis
7. North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Product and Services
7.1 Overview
7.2 In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)
7.3 Reagents & Kits
7.3.1 Overview
7.3.2 Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments Market Revenue and Forecast to 2027 (US$ Mn)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services Market Revenue and Forecast to 2027 (US$ Mn)
8. North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Technology
8.1 Overview
8.2 In-Vitro Diagnostics Market, by Technology, 2019 & 2027 (% Share)
8.3 Immunoassay/Immunochemistry
8.3.1 Overview
8.3.2 Immunoassay/Immunochemistry Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Clinical Chemistry
8.4.1 Overview
8.4.2 Clinical Chemistry Market Revenue and Forecast to 2027 (US$ Mn)
8.5 Molecular Diagnostics
8.5.1 Overview
8.5.2 Molecular Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.6 Microbiology
8.6.1 Overview
8.6.2 Microbiology Market Revenue and Forecast to 2027 (US$ Mn)
8.7 Blood Glucose Self-Monitoring
8.7.1 Overview
8.7.2 Blood Glucose Self-Monitoring Market Revenue and Forecast to 2027 (US$ Mn)
8.8 Coagulation and Hemostasis
8.8.1 Overview
8.8.2 Coagulation and Hemostasis Market Revenue and Forecast to 2027 (US$ Mn)
8.9 Haematology
8.9.1 Overview
8.9.2 Haematology Market Revenue and Forecast to 2027 (US$ Mn)
8.10 Urinalysis
8.10.1 Overview
8.10.2 Urinalysis Market Revenue and Forecast to 2027 (US$ Mn)
8.11 Others
8.11.1 Overview
8.11.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
9. North America In-Vitro Diagnostics Market Analysis and Forecasts To 2027 – By Application
9.1 Overview
9.2 In-Vitro Diagnostics Market, by Application, 2019 & 2027 (% Share)
9.3 Infectious Diseases
9.3.1 Overview
9.3.2 Infectious Diseases Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Diabetes
9.4.1 Overview
9.4.2 Diabetes Market Revenue and Forecast to 2027 (US$ Mn)
9.5 Oncology
9.5.1 Overview
9.5.2 Oncology Market Revenue and Forecast to 2027 (US$ Mn)
9.6 Cardiology
9.6.1 Overview
9.6.2 Cardiology Market Revenue and Forecast to 2027 (US$ Mn)
9.7 Autoimmune Disease
9.7.1 Overview
9.7.2 Autoimmune Disease Market Revenue and Forecast to 2027 (US$ Mn)
9.8 Nephrology
9.8.1 Overview
9.8.2 Nephrology Market Revenue and Forecast to 2027 (US$ Mn)
9.9 Others
9.9.1 Overview
9.9.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
10. North America In-Vitro Diagnostics Market Analysis and Forecasts to 2027– By End user
10.1 Overview
10.2 In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
10.4 Laboratories
10.4.1 Overview
10.4.2 Laboratories Market Revenue and Forecast to 2027 (US$ Mn)
10.5 Homecare
10.5.1 Overview
10.5.2 Homecare Market Revenue and Forecast to 2027 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others Market Revenue and Forecast to 2027 (US$ Mn)
11. In-Vitro Diagnostics Market Revenue and Forecasts to 2027 – Geographical Analysis
11.1 North America In-Vitro Diagnostics Market Revenue And Forecast To 2027
11.1.1 North America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)
11.1.2 US
11.1.2.1 US In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.2.1.1 US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)
11.1.2.1.2 US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.2.1.3 US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.2.1.4 US In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
11.1.3 Canada
11.1.3.1 Canada In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.3.1.1 Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)
11.1.3.1.2 Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.3.1.3 Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.3.1.4 Canada In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
11.1.4 Mexico
11.1.4.1 Mexico In-Vitro Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
11.1.4.1.1 Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Product & Services (US$ Mn)
11.1.4.1.2 Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Technology (US$ Mn)
11.1.4.1.3 Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By Application (US$ Mn)
11.1.4.1.4 Mexico In-Vitro Diagnostics Market Revenue And Forecast to 2027, By End User (US$ Mn)
12. Impact Of COVID-19 Pandemic on North America In-Vitro Diagnostics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
13.2 Organic Developments Done by The Companies in The Market
13.3 Inorganic Developments Done by The Companies in The Market
14. COMPANY PROFILES
14.1 Abbott
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Danaher
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Siemens AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corporation
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BD
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 QIAGEN
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms

Table 1. Key launches 2016: By Roche
Table 2. US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)
Table 3. US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 4. US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 5. US In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 6. Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)
Table 7. Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 8. Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 9. Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 10. Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Product & Services (US$ Mn)
Table 11. Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Technology (US$ Mn)
Table 12. Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By Application (US$ Mn)
Table 13. Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027, By End User (US$ Mn)
Table 14. Organic Developments Done by The Companies
Table 15. Inorganic Developments Done by The Companies
Table 16. Glossary of Terms, In-Vitro Diagnostics Market

Figure 1. In-Vitro Diagnostics Market Segmentation
Figure 2. North America In-Vitro Diagnostics Market Overview
Figure 3. Reagents and Kits Segment Held Largest Share of Product and Services in In-Vitro Diagnostics Market
Figure 4. Infectious Diseases Segment Held Largest Share of Application in In-Vitro Diagnostics Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. In-Vitro Diagnostics Market - North America PEST Analysis
Figure 7. In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints
Figure 8. North America In-Vitro Diagnostics Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. In-Vitro Diagnostics, by Product and Services, 2019 & 2027 (% Share)
Figure 10. Reagents & Kits Market Revenue and Forecast to 2027 (US$ Mn)
Figure 11. Instruments Market Revenue and Forecast to 2027 (US$ Mn)
Figure 12. Software & Services Market Revenue and Forecast to 2027 (US$ Mn)
Figure 13. In-Vitro Diagnostics Market, By Technology, 2019 & 2027 (% Share)
Figure 14. Immunoassay/Immunochemistry Market Revenue And Forecast To 2027 (US$ Mn)
Figure 15. Clinical Chemistry Market Revenue And Forecast To 2027 (US$ Mn)
Figure 16. Molecular Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 17. Microbiology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 18. Blood Glucose Self-Monitoring Market Revenue And Forecast To 2027 (US$ Mn)
Figure 19. Coagulation and Hemostasis Market Revenue And Forecast To 2027 (US$ Mn)
Figure 20. Hematology Market Revenue and Forecast to 2027 (US$ Mn)
Figure 21. Urinalysis Market Revenue And Forecast To 2027 (US$ Mn)
Figure 22. Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 23. In-Vitro Diagnostics Market, By Application, 2019 & 2027 (% Share)
Figure 24. Infectious Diseases Market Revenue And Forecast To 2027 (US$ Mn)
Figure 25. Diabetes Market Revenue And Forecast To 2027 (US$ Mn)
Figure 26. Most Prevalent Forms of Cancers Globally, 2018
Figure 27. Oncology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 28. Cardiology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 29. Autoimmune Disease Market Revenue And Forecast To 2027 (US$ Mn)
Figure 30. Nephrology Market Revenue And Forecast To 2027 (US$ Mn)
Figure 31. Others Market Revenue And Forecast To 2027 (US$ Mn)
Figure 32. In-Vitro Diagnostics Market Share by End User 2019 & 2027 (%)
Figure 33. Hospitals Market Revenue And Forecast To 2027 (US$ Mn)
Figure 34. Laboratories Market Revenue And Forecast To 2027 (US$ Mn)
Figure 35. Homecare Market Revenue And Forecast To 2027 (US$ Mn)
Figure 36. Others Market Revenue and Forecast to 2027 (US$ Mn)
Figure 37. North America In-Vitro Diagnostics Market Revenue, By Country, 2019 (US$ Mn)
Figure 38. North America In-Vitro Diagnostics Market Revenue and Forecast to 2027, By Country (%)
Figure 39. US In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 40. Canada In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 41. Mexico In-Vitro Diagnostics Market Revenue And Forecast To 2027 (US$ Mn)
Figure 42. Impact of COVID-19 Pandemic in North American Country Markets
Figure 43. Growth Strategies Done by the Companies in the Market, (%)